A study found that sentinel lymph node biopsy rarely missed remaining cancer in patients with locally advanced breast cancer whose lymph nodes responded to chemotherapy before surgery.
|Podcasts|March 1, 2018
Barbells for Boobs
Author(s)Brielle Benyon
What happens when a 20-something finds a cancerous lump in her breast and is told to come back for a mammogram at the age of 40? For one group of CrossFit fanatics, it meant the launch of a nonprofit to raise money and spread awareness about breast cancer.
Advertisement
What happens when a 20-something finds a cancerous lump in her breast and is told to come back for a mammogram at the age of 40? For one group of CrossFit fanatics, it meant the launch of a nonprofit to raise money and spread awareness about breast cancer.
Read more:
Advertisement
Related to this article
Lower income, later diagnosis and gaps in treatment drove most of the excess deaths among rural patients, according to new research.
The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer will come back within five and 10 years.
Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the gratitude of living beyond cancer.
In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the screening visit, but its 24% lower rate of cancers found between screenings was not statistically significant.
Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed her care.
Debbie Legault, whose daughter was diagnosed with breast cancer at 27, urges shoppers to skip pink ribbon products and donate directly to support organizations.
A psycho-oncologist answers 5 common questions about cancer-related anxiety, depression, fear of recurrence and emotional well-being.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
2
Diagnosed With Sarcoma at 21, She Found Her People at Mary's Place
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
Gemcitabine Plus BCG Clears Bladder Cancer in 96% of Patients After BCG Failure
5